Skip to main content
SpringerLink
Log in

Obstetric APS

  • Chapter
  • First Online:
Antiphospholipid Antibody Syndrome

Part of the book series: Rare Diseases of the Immune System ((RDIS))

  • 1456 Accesses

Abstract

Antiphospholipid syndrome (APS) was first described in patients with obstetric morbidity. In the frame of APS, several obstetrical problems have been identified: recurrent pregnancy loss, fetal death, preterm delivery, intrauterine growth restriction, early severe preeclampsia, and even HELLP syndrome. Nevertheless the association between pregnancy loss or complications and aPL antibodies has been differently reported in various studies because of the diverse inclusion criteria and the lack of standardization in the antibody detection methods. Another matter of controversies is the lack of uniform definitions for pregnancy loss that in many cases is outdated and not reflective of modern understanding of reproductive biology. Antiphospholipid antibody profile has also been investigated as possible risk factor for pregnancy loss recurrence: patients with triple antiphospholipid positivity seem to carry a higher risk for recurrency even in treated pregnancies. In contrast with what describe in thrombotic APS, low titer aPL (aCL and anti-β2GPI) and the presence of other “non-criteria” aPL (aPE, aPT, aPT/PS, anti-annexin 5) could be of significance in obstetric APS being associated with poor obstetric outcome. To achieve a successful outcome in APS pregnancy, an adequate pregnancy management is required and includes not only a proper treatment but also a coordinated medical–obstetrical care, a close follow-up protocol, and a good neonatal intensive care unit.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Soulier JP, Boffa M (1980) Recurrent abortion, thrombosis and circulating antithromboplastin type anticoagulant. Nouv Presse Med 9:859–864

    Google Scholar 

  2. Wilson WA, Gharavi AE, Koike T et al (1999) International consensus statement on preliminary classification for definite antiphospholipid syndrome. Arthritis Rheum 42:1309–1311

    Article  CAS  PubMed  Google Scholar 

  3. Miyakis S, Lockshin MD, Atsumi T et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome(APS). J Thromb Haemost 4:295–306

    Article  CAS  PubMed  Google Scholar 

  4. Asherson RA (2006) New subsets of the antiphospholipid syndrome in 2006: “PRE-APS” (probable APS) and microangiopathic antiphospholipid syndromes (“MAPS”). Autoimmun Rev 6:76–80

    Article  PubMed  Google Scholar 

  5. Cervera R, Serrano R, Pons Estel GJ et al (2014) Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicenter prospective study of 1000 patients. Ann Rheum Dis. doi: 10.1136/annrheumdis-2013-204838. [Epub ahead of print]

    Google Scholar 

  6. Ruffatti A, Tonello M, Visentin M et al (2011) Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case–control study. Rheumatology 50:1684–1689

    Article  CAS  PubMed  Google Scholar 

  7. Lockshin MD et al (2012) Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies. Arthritis Rheum 64:2311–2318

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Pierangeli SS, De Groot PG, Dlott J et al (2011) ‘Criteria’aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, Texas, April 2010. Lupus 20(2):182–190

    Article  CAS  PubMed  Google Scholar 

  9. Mekinian A, Loire-Berson P, Nicaise-Roland P et al (2012) Outcomes and treatment of obstetrical antiphospholipid syndrome in women with low antiphospholipid antibody levels. J Reprod Immunol 94(2):222–226

    Article  PubMed  Google Scholar 

  10. Simchen MJ, Dulitzki M, Rofe G et al (2011) High positive antibody titers and adverse pregnancy outcome in women with antiphospholipid syndrome. Acta Obstet Gynecol Scand 90(12):1428–1433

    Article  PubMed  Google Scholar 

  11. Gardiner C, Hills J, Machin S et al (2013) Diagnosis of antiphospholipid syndrome in routine clinical practice. Lupus 22(1):18–25

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  12. Boffa MC, Boinot C, De Carolis S et al (2009) Laboratory criteria of the obstetrical antiphospholipid syndrome. Data from a multicentric prospective European women cohort. Thromb Haemost 102(1):25–28

    CAS  PubMed  Google Scholar 

  13. Silver RM, Parker CB, Reddy UM et al (2013) Antiphospholipid antibodies in stillbirth. Obstet Gynecol 122(3):641–657

    Article  CAS  PubMed  Google Scholar 

  14. Yetman DL, Kutteh WH (1996) Antiphospholipid antibody panels and recurrent pregnancy loss: prevalence of anticardiolipin antibodies compared with other antiphospholipid antibodies. Fertil Steril 66:540–546

    CAS  PubMed  Google Scholar 

  15. Matsubayashi H, Sugi T, Arai T et al (2001) Different antiphospholipid antibody specificities are found in association with early repeated pregnancy loss versus recurrent IVF-failure patients. Am J Reprod Immunol 46:323–329

    Article  CAS  PubMed  Google Scholar 

  16. Sanmarco M, Bardin N, Camoin L et al (2007) Antigenic profile, prevalence, and clinical significance of antiphospholipid antibodies in women referred for in vitro fertilization. Ann N Y Acad Sci 1108:457–465

    Article  CAS  PubMed  Google Scholar 

  17. Yamada H, Atsumi T, Kobashi G et al (2009) Antiphospholipid antibodies increase the risk of pregnancy-induced hypertension and adverse pregnancy outcomes. J Reprod Immunol 79:188–195

    Article  CAS  PubMed  Google Scholar 

  18. Sater MS, Ramzi RF, Farah MA et al (2012) Anti-phosphatidylserine, anti-cardiolipin, anti-beta 2 glycoprotein I and anti-prothrombin antibodies in recurrent miscarriage at 8–12 gestational weeks. Eur J Obstet Gynecol Reprod Biol 163:170–174

    Article  CAS  PubMed  Google Scholar 

  19. Marozio L, Curti A, Botta G et al (2011) Antipropthrombin antibodies are associated with adverse pregnancy outcome. Am J Reprod Immunol 66:404–409

    Article  CAS  PubMed  Google Scholar 

  20. Tsutsumi A, Atsumi T, Yamada H et al (2001) Anti-phosphatidylserine/prothrombin antibodies are not frequently found in patients with unexplained recurrent miscarriages. Am J Reprod Immunol 46:242–244

    Article  CAS  PubMed  Google Scholar 

  21. Žigon P, Čučnik S, Ambrožič A et al (2013) Detection of antiphosphatidylserine/prothrombin antibodies and their potential diagnostic value. Clin Dev Immunol 2013

    Google Scholar 

  22. Sater MS, Finanb RR, Mustafa FE et al (2011) Anti-annexin V IgM and IgG antibodies and the risk of idiopathic recurrent spontaneous miscarriage. J Reprod Immunol 89:78–83

    Article  CAS  PubMed  Google Scholar 

  23. Bizzaro N, Antico A, Musso M et al (2005) A prospective study of 1038 pregnancies on the predictive value of anti-annexin V antibodies for foetal loss. Ann N Y Acad Sci 1050:348–356

    Article  CAS  PubMed  Google Scholar 

  24. Alijotas-Reig J, Ferrer-Oliveras R, Rodrigo-Anoro MJ et al (2010) Anti-annexin A5 antibodies in women with spontaneous pregnancy loss. Med Clin (Barc) 134:433–438

    Article  Google Scholar 

  25. Rand JH, Wu XX, Quinn AS et al (2010) The annexin A5-mediated pathogenic mechanism in the antiphospholipid syndrome: role in pregnancy losses and thrombosis. Lupus 19:460–469

    Article  CAS  PubMed  Google Scholar 

  26. Zatti S, Biasini Rebaioli C, Lojacono A et al (2006) Antiphospholipid syndrome and pregnancy. Womens Health 2:873–880

    CAS  Google Scholar 

  27. Silver RM, Branch DW, Goldenberg R et al (2011) Nomenclature for pregnancy outcomes: time for a change. Obstet Gynecol 118(6):1402–1408

    Article  PubMed  Google Scholar 

  28. Andreoli L, Chighizola CB, Banzato A et al (2013) Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature. Arthritis Care Res 65(11):1869–1873

    Article  CAS  Google Scholar 

  29. Opatrny L, David M, Kahn SR et al (2006) Association between antiphospholipid antibodies and recurrent fetal loss in women without autoimmune disease: a metaanalysis. J Rheumatol 33(11):2214–2221

    CAS  PubMed  Google Scholar 

  30. de Jesus GR, Agmon-Levin N, Andrade C et al (2014) 14th International Congress on Antiphospholipid Antibodies Task Force report on obstetric antiphospholipid syndrome. Autoimmun Rev. 13(8):795–813

    Google Scholar 

  31. Panton JA, Kilpatrick DC (1997) Anti-cardiolipin antibodies in sexual partners of recurrent aborters. Hum Reprod 12(3):464–467

    Article  CAS  PubMed  Google Scholar 

  32. Zammiti W, Mtiraoui N, Hidar S et al (2006) Antibodies to beta2-glycoprotein I and annexin V in women with early and late idiopathic recurrent spontaneous abortions. Arch Gynecol Obstet 274(5):261–265

    Article  CAS  PubMed  Google Scholar 

  33. Hossain N, Shamsi T, Khan N et al (2013) Thrombophilia investigation in Pakistani women with recurrent pregnancy loss. J Obstet Gynaecol Res 39(1):121–125

    Article  PubMed  Google Scholar 

  34. Lee RM, Branch DW, Silver RM (2001) Immunoglobulin A anti-beta2-glycoprotein antibodies in women who experience unexplained recurrent spontaneous abortion and unexplained fetal death. Am J Obstet Gynecol 185(3):748–753

    Article  CAS  PubMed  Google Scholar 

  35. Alijotas-Reig J, Ferrer-Oliveras R, Rodrigo-Anoro MJ et al (2010) Anti-beta(2)-glycoprotein-I and anti-phosphatidylserine antibodies in women with spontaneous pregnancy loss. Fertil Steril 93(7):2330–2336

    Article  CAS  PubMed  Google Scholar 

  36. Mtiraoui N, Fekih M, Zammiti W et al (2007) Lupus anticoagulant and antibodies to beta 2-glycoprotein I, annexin V, and cardiolipin as a cause of recurrent spontaneous abortion. Fertil Steril 88(5):1458–1461

    Article  CAS  PubMed  Google Scholar 

  37. Lee RM, Emlen W, Scott JR et al (1999) Anti-beta2-glycoprotein I antibodies in women with recurrent spontaneous abortion, unexplained fetal death, and antiphospholipid syndrome. Am J Obstet Gynecol 181(3):642–648

    Article  CAS  PubMed  Google Scholar 

  38. Carreras LO, Vermylen J, Spitz B et al (1981) Lupus anticoagulant and inhibition of prostacyclin formation in patients with repeated abortion, intrauterine growth retardation and intrauterine death. Br J Obstet Gynaecol 88:890–894

    Article  CAS  PubMed  Google Scholar 

  39. Goldstein SR (1994) Embryonic death in early pregnancy: a new look at the first trimester. Obstet Gynecol 84:294–297

    CAS  PubMed  Google Scholar 

  40. Frias AE, Luikenaar RA, Sullivan AE et al (2004) Poor obstetric outcome in subsequent pregnancies in women with prior fetal death. Obstet Gynecol 104:521–526

    Article  PubMed  Google Scholar 

  41. Tincani A, Bazzani C, Zingarelli S et al (2008). Lupus and the antiphospholipid syndrome in pregnancy and obstetrics: clinical characteristics, diagnosis, pathogenesis, and treatment. In: Seminars in thrombosis and hemostasis, vol. 34, no. 3. Stratton Intercontinental Medical Book Corporation, New York, pp 267–273, c1974-

    Google Scholar 

  42. Oshiro BT, Silver RM, Scott JR et al (1996) aPL and fetal death. Obstet Gynecol 87:489–493

    Article  CAS  PubMed  Google Scholar 

  43. Battinelli EM, Marshall A, Connors JM (2013) The role of thrombophilia in pregnancy. Thrombosis 2013

    Google Scholar 

  44. Abou-Nassar K, Carrier M, Ramsay T et al (2011) The association between antiphospholipid antibodies and placenta mediated complications: a systematic review and meta-analysis. Thromb Res 128(1):77–85

    Article  CAS  PubMed  Google Scholar 

  45. Lima F, Khamashta MA, Buchanan NM et al (1996) A study of sixty pregnancies in patients with the antiphospholipid syndrome. Clin Exp Rheumatol 14:131–136

    CAS  PubMed  Google Scholar 

  46. Costedoat-Chalumeau N, Guettrot-Imbert G, Le Guern V et al (2012) Pregnancy and antiphospholipid syndrome. Revue de Medecine Interne 33:209–216

    Google Scholar 

  47. Clark EA, Silver RM, Branch DW (2007) Do antiphospholipid antibodies cause preeclampsia and HELLP syndrome? Curr Rheumatol Rep 9(3):219–225

    Article  CAS  PubMed  Google Scholar 

  48. Moodley J, Bhoola V, Duursma J et al (1995) The association of antiphospholipid antibodies with severe early-onset preeclampsia. S Afr Med J 85:105–107

    CAS  PubMed  Google Scholar 

  49. Allen JY, Tapia-Santiago C, Kutteh WH (1996) Antiphospholipid antibodies in patients with preeclampsia. Am J Reprod Immunol 36:81–85

    Article  CAS  PubMed  Google Scholar 

  50. Branch DW, Andres R, Digre KB et al (1989) The association of antiphospholipid antibodies with severe pre-eclampsia. Obstet Gynecol 73:541–545

    CAS  PubMed  Google Scholar 

  51. do Prado AD, Piovesan DM, Staub HL et al (2010) Association of anticardiolipin antibodies with preeclampsia: a systematic review and meta-analysis. Obstet Gynecol 116(6):1433–1443

    Article  PubMed  Google Scholar 

  52. Branch DW, Silver RM, Blackwell JL et al (1992) Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet Gynecol 80:614–620

    CAS  PubMed  Google Scholar 

  53. Caruso A, de Carolis S, Ferrazzani S et al (1993) Pregnancy outcome in relation to uterine artery flow velocity waveforms and clinical characteristics in women with antiphospholipid syndrome. Obstet Gynecol 1993(82):970–977

    Google Scholar 

  54. Polzin WJ, Kopelman JN, Robinson RD et al (1991) The association of aPL with pregnancies complicated by fetal growth restriction. Obstet Gynecol 1991(78):1108–1111

    Google Scholar 

  55. Sletnes KE, Wisloff F, Moe N et al (1992) Antiphospholipid antibodies in pre-eclamptic women: relation to growth retardation and neonatal outcome. Acta Obstet Gynecol Scand 1992(71):112–117

    Article  Google Scholar 

  56. Yasuda M, Takakuwa K, Tokunaga A et al (1995) Prospective studies of the association between anticardiolipin antibody and outcome of pregnancy. Obstet Gynecol 86:555–559

    Article  CAS  PubMed  Google Scholar 

  57. Pattison NS, Chamley LW, McKay EJ et al (1993) Antiphospholipid antibodies in pregnancy: prevalence and clinical associations. Br J Obstet Gynaecol 100:909–913

    Article  CAS  PubMed  Google Scholar 

  58. Lynch A, Marlar R, Murphy J et al (1994) Antiphospholipid antibodies in predicting adverse pregnancy outcome: a prospective study. Ann Intern Med 1994(120):470–475

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Rheumatology and Clinical Immunology, Spedali Civili, University of Brescia, Piazzale Spedali Civili, 1, Brescia, 25123, Italy

    Micaela Fredi & Angela Tincani MD

Authors
  1. Micaela Fredi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Angela Tincani MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Angela Tincani MD .

Editor information

Editors and Affiliations

  1. Department of Rheumatology, Gaetano Pini Institute, Milan, Milano, Italy

    Pier Luigi Meroni

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Fredi, M., Tincani, A. (2015). Obstetric APS. In: Meroni, P. (eds) Antiphospholipid Antibody Syndrome. Rare Diseases of the Immune System. Springer, Cham. https://doi.org/10.1007/978-3-319-11044-8_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-11044-8_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-11043-1

  • Online ISBN: 978-3-319-11044-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation